VEGA 1/0546/16
Antiproliferative effects of newly synthesized jaspin B analogs and their effect on tumor angiogenesis
Duration of project: 2016 – 2019
VEGA 1/0204/16
Influence of cytostatic treatment on the dynamics of expression of factors causing drug resistance in experimentally induced breast cancer
Duration of project: 2016 – 2019
VEGA 1/0660/16
Do galectins mediate the protective effect of estrogens/phytoestrogens on the heart after myocardial infarction ?
Principal investigator: MUDr. Tomáš Toporcer, PhD.
Duration of project: 2016 – 2019
VEGA 1/0873/18
Biomarkers of the development of competence of human embryos and receptivity of the endometrium in women with recurrent implantation failure
Principal investigator: prof. MUDr. Peter Urdzík, PhD.
Duration of project: 2018 – 2020
VEGA 1/0658/20
Combined treatment of glioblastoma with temozolomide and secondary metabolites of lichens
Principal investigator: RNDr. Terézia Kisková, PhD.
Duration of project: 2020 – 2023
VEGA 1/0723/21
Monitoring the impact of occlusion of the middle cerebral artery using connectomic data
Principal investigator: RNDr. Martin Bona, PhD.
Duration of project: 2021 – 2024
APVV APVV-21-0069
Secretome of blood elements as a source of bioactive factors mediating neuroprotection
Principal investigator: RNDr. Martin Bona, PhD.
Duration of project: 2022 – 2026
VVGS PCOV ID2678
Acceleration of the technological procedure of decalcification of bone tissues using ultrasound waves and modified decalcification solutions while maintaining the quality of the histomorphological image
Principal investigator: MUDr. Adam Nedoroščík
Duration of project: 2023 – 2024
VVGS IPEL ID2679
Digitization of the histopathology collection of the Institute of Pathology of the UPJŠ FM for the purpose of improving the educational opportunities of students at the pregradual level of study at the University of Pavol Jozef Šafárik in Košice
Principal investigator: MUDr. Alžbeta Blichárová, PhD.
Duration of project: 2023 – 2024
